Importantly, results from large clinical trials showed strong augmentation of efficacy of radiotherapy (RT) for aggressive PCa when combined with anti-androgen therapy, suggesting a potential role for AR inhibition in dampening DDR. The gene discussed is AR; the disease is posterior cortical atrophy.